Later studies showed that CD19 splice variants lacking exon 2 were also detected in B-ALL pediatric patients at diagnosis and could be the cause of initial leukemia resistance to CD19-targeting CAR-T treatment [103]. This evidence concerns the gene CD19 and leukemia.